跳至主要内容
临床试验/NCT03758820
NCT03758820已完成不适用

Multicenter Study, Randomized, Parallel Group Controlled, Testing the Effectiveness of a Behavioral Cognitive Therapy (BCT) vs Usual Local Practice on the Fatigue of Patients With Relapsing Remittent Multiple Sclerosis (RRMS)

Réseau Sep Idf Ouest2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2017年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
105
试验地点
2
主要终点
Change assessment from Baseline measure of Fatigue Impact to month 6, 12 and 18

研究概览

简要总结

Multiple sclerosis (MS) is a chronic inflammatory disease that leads to demyelination of the central nervous system. Fatigue is one of the most frequent and most disabling symptoms of MS. Up to 86% of individuals with MS experience fatigue at any one time; 65% consider it to be one of their three most troubling symptoms. Fatigue may limit or prevent participation in dayly activities and reduce psychological well-being (1, 2). Pharmacological and non-pharmacological treatments are available for MS-related fatigue, but evidence on effectiveness is mostly inconclusive or non-existent. The psychological approaches of fatigue management are interesting. To date, three RCTs using cognitive-behavioral group-based approaches in MS fatigue management programs have demonstrated their effectiveness (3-6). The results demonstrated a reduction in fatigue scores and better self-management of the disease in general. However, if these programs are effective at the time of their application and in the medium term, the issue of maintaining long-term therapeutic benefits is problematic.

The aim of this research is to assess the effectiveness of the FACETS program (6), on a population of French patients with RRMS over a 18 month period. This program focuses on the management of fatigue and is based on a conceptual framework that incorporates elements of cognitive-behavioral, self-efficacy, self-management and energy effectiveness theories. It consists of six once-weekly sessions of 90 minutes, with homework activities between the sessions. It is designed for groups of 6 to 10 people. The investigators propose to add 4 booster sessions to the FACETS program, at week 6, 12, 18 et 36 after the end of the program, in order to activate and reinforce the cognitive and behavioral processes and enhance the benefits of FACETS in the longer term.

This trial is randomized controlled comparative comparing a group receiving a FACETS program with a group receiving only a current local practice. Socio-demographic and medical data are measured as well as fatigue impact, fatigue severity, anxiety and depression, sleep disorder and quality of life.

The expected results are a significantly greater decrease in fatigue severity and impact in the FACETS group than the control group post intervention and this difference will be maintained at 1 year.

详细描述

In spite of the fatigue impact is well known in MS, medical care of this symptom is not usual. Moreover, treatments of fatigue are available, but evidence for effectiveness is limited. This study will build upon the existing evidence base for the effectiveness of cognitive behavioral approaches, and particularly the recent FACETS trial published by co-applicants.

Scientific aim is to assess the effectiveness of the FACETS program plus 4 additional booster sessions on a population of French patients with RRMS over a 12 months period.

This study will provide evidence on whether the FACETS program plus booster sessions is effective in helping MS patients with their fatigue. The program is designed to facilitate use within health services. Thus, if the results from this trial are positive, there is potential for directly adding to the treatment options available to MS patients who have troublesome fatigue, and improving the central nervous system affecting approximately 2.5 million people (5). Fatigue is one of the most commonly reported and disabling symptoms of MS, often occurring daily (6) and with a variable course (7-8). Up to 86% of individuals with MS experience fatigue at any one time; 65% consider it to be one of their three most troubling symptoms. Fatigue has been defined as a "subjective lack of physical and/or mental energy that is perceived by the individual or caregiver to interfere with usual or desired activities" (9).

Researchers have distinguished between primary and secondary fatigue (10). "Primary" fatigue relates to aspects of fatigue deemed to be directly related to the disease process such as lassitude or asthenia (an overwhelming sense of tiredness not directly related to participation in activity or exercise), "short-circuiting" fatigue (when muscular performance deteriorates during sustained activity but recovers after a short rest break) and heat sensitive fatigue (where fatigue is triggered or worsened by heat). "Secondary" fatigue refers to fatigue that is not unique to MS and is related to factors common to a range of chronic and disabling conditions (e.g. sleep disturbance, medication side effects, infection, physical exertion, depression, anxiety, stressful life events, characteristics of the local environment - such as lighting and temperature within a work setting). The relationship between these dimensions is complex; various symptoms of MS may act as predisposing factors for secondary fatigue.

Fatigue may limit or prevent participation in everyday activities, work, leisure and social pursuits, restrict role fulfilment and reduce psychological well-being (1-2) and is one of the key precipitants of early retirement (11-12). Its 'invisible' nature may lead to difficulties in personal and work relationships (13-14).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

盲法说明

randomization of patients

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • EDSS ≤ 5,5
  • MFIS score > 45
  • Outpatient treatment
  • Enable to follow the BCT sessions
  • French understanding
  • More than 18 years old
  • Inform consent signature
  • Membership in a social protection

排除标准

  • Cognitive disorders avoiding patient participation
  • Relapse within last 3 months before baseline
  • Onset of DMT within 3 months
  • Onset of antidepressive treatment within 3 months
  • Onset of treatment for fatigue within 3 months
  • Psychiatric disorders

结局指标

主要结局

Change assessment from Baseline measure of Fatigue Impact to month 6, 12 and 18

时间窗: After 6 weeks and 6,12 and 18 months

Fatigue impact evaluated by MFIS autoquestionnaire MFIS : Modified Fatigue Impact Scale, 5 response option (0 to 4), score of between 0 (better) and 84 (worse) : A score \> 45 means the patient is affected by fatigue.

次要结局

  • Change assessment from Baseline of Quality of life: MSIS-29(After 6,12 and 18 months)
  • Change assessment from Baseline of Anxiety and depression(After 12 months)
  • Change assessment from Baseline of Quality of sleep: Pittsburgh Sleep Quality scale(After 12 months)
  • Change assessment from Baseline of Quality of life: EQ5D-3L(After 6,12 and 18 months)
  • Change assessment from Baseline of Fatigue severity(After 6 weeks and 6 and 12 months)
  • Change assessment from Baseline of Quality of sleep: Epworth Sleepiness Scale(After 12 months)
  • Change assessment from Baseline of Medical care consumption and professional impact(After 6,12 and 18 months)
  • Change assessment from Baseline of professional impact(After 6,12 and 18 months)
  • Change assessment from Baseline of Cognitive disorders(After 12 months)

研究者

发起方
Réseau Sep Idf Ouest
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Behavior Cognitive Therapy on Fatigue Impact in MS... | 临床试验